Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 3 of 3 for “"Transthyretin Amyloidosis"”.

  1. Transthyretin Amyloidosis: Proteolytic cleavage accelerates G53A TTR misfolding and aggregation

    … peptide bond and also associated with TTR amyloidosis, was investigated in thepresence and absence of proteolytic agent, trypsin. Fragmented G53A TTR misfolded and aggregated via a similar mechanism as full-length TTR, but at a faster rate. Similar morphology was exhibited by fragmented and …

    ecu Repository record for Transthyretin Amyloidosis: Proteolytic cleavage accelerates G53A TTR misfolding and aggregation (opens in a new tab)

  2. Liver transplantation for transthyretin amyloidosis: experience of a single center in Italy

    … is the only definitive treatment for transthyretin amyloidosis, with an excellent 5-year survival in endemic countries where the Met30 mutation is predominant. We report our experience of liver transplantation for transthyretin amyloidosis. We reviewed the clinical records of 17 …

    bologna Repository record for Liver transplantation for transthyretin amyloidosis: experience of a single center in Italy (opens in a new tab)

  3. Determinants and Monitoring of Response to Disease-Modifying Therapy for Transthyretin Amyloidosis Cardiomyopathy: The ATTR-CM Therapy Study

    Transthyretin amyloidosis cardiomyopathy (ATTR-CM) is a heart muscle disease characterized by the accumulation of misfolded transthyretin proteins as amyloid plaques in the myocardial interstitium. In 2020, tafamidis, a medication inhibiting the misfolding of transthyretin, received Health Canada's …

    calgary Repository record for Determinants and Monitoring of Response to Disease-Modifying Therapy for Transthyretin Amyloidosis Cardiomyopathy: The ATTR-CM Therapy Study (opens in a new tab)